Trial of a capripoxvirus-rinderpest recombinant vaccine in African cattle

Epidemiology and Infection

Volumn 118, Issue 1, 1997, Pages 63-70

  Ngichabe, C K ^a   Wamwayi, H M ^a   Barrett, T ^b   Ndungu, E K ^a   Black, D N ^b   Bostock, C J ^b  

^a KENYA AGRICULTURAL RESEARCH INSTITUTE   (Kenya)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; HYBRID PROTEIN; RECOMBINANT VACCINE;

AFRICA; ANIMAL EXPERIMENT; ARTICLE; CAPRIPOXVIRUS; CATTLE DISEASE; CATTLE PLAGUE VIRUS; CONTROLLED STUDY; NONHUMAN; PROVOCATION TEST; TIME; VACCINATION;

ANIMALS; CATTLE; HEMAGGLUTININS; LUMPY SKIN DISEASE; LUMPY SKIN DISEASE VIRUS; NEUTRALIZATION TESTS; RINDERPEST; RINDERPEST VIRUS; VACCINATION; VACCINES, SYNTHETIC; VIRAL FUSION PROTEINS;

EID: 0031053020     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268896007200     Document Type: Article

References (19)

1. Cam VM. Rinderpest and lumpy skin disease. Cattle Pract 1995; 3: 9-12.
2. Mariner JC, House JA, Sollod A, Stem C, Van den Ende M, Mebus CA. Comparison of the effect of various chemical stabilizers and lyophilization cycles on the thermo-stability of a vero cell-adapted rinderpest vaccine. Vet Microbiol 1990; 21: 195-209.
3. Mariner JC, House JA, Mebus CA, Sollod A, Stem C. Production of a themostable Vero cell-adapted rinderpest vaccine. J Tiss Cult Meth 1991; 128: 253-6.
4. Limbach KJ. Non-replicating expression vectors: applications in vaccine development and gene therapy. Epidemiol Infect 1995; 116: 241-56.
5. Belsham GJ, Anderson EC, Murray PK, Anderson J, Barrett T. Immune response and protection of cattle and pigs generated by a vaccinia virus recombinant expressing the F protein of rinderpest virus. Vet Rec 1989; 124: 655-8.
6. Asano K, Tsukiyama K, Shibata S, et al. Immunological and virological characterisation of improved construction of recombinant vaccinia virus expressing rinderpest virus haemagglutinin. Arch Virol 1991; 116: 81-90.
7. Giavedoni L, Jones L, Mebus C, Yilma T. A vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions. Proc Natl Acad Sci USA 1991; 88: 8011-5.
8. Pastoret P-P, Brochier B. The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link betwen Jenner and Pasteur. Epidemiol Infect 1996; 116: 235-40.
9. Brochier B, Boulanger D, Costy F, Pastoret P-P. Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virus. Vaccine 1994; 12: 1368-71.
10. Kitching RP, Hammond JM, Taylor WP. A single vaccine for the control of capripox infection in sheep and goats. Res Vet Sci 1987; 42: 53-60.
11. Romero CH, Barrett T, Evans SA, et al. Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine 1993; 11: 737-42.
12. Romero CH, Barrett T, Chamberlain R, Kitching RP, Fleming M, Black DN. Recombinant capripoxvirus expressing the haemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses. Virology 1994; 204: 425-9.
13. Romero CH, Barrett T, Kitching RP, Carn VM, Black DN. Protection of cattle against rinderpest and lumpy skin skin disease with a recombinant expressing the fusion protein gene of rinderpest virus. Vet Rec 1994; 135: 152-4.
14. Davies FG, Atema C. The antibody response in sheep to infection with a Kenyan sheep and goat pox virus. J Comp Pathol 1978; 88: 205-10.
15. Yamanouchi K, Inui K, Sugimoto M, et al. Immunisation of cattle with a recombinant vaccinia vector expressing the haemagglutinin gene of rinderpest virus. Vet Rec 1993; 132: 152-6.
16. Inui K, Barrett T, Kitching RP, Yamanouchi K. Long-term immunity in cattle vaccinated with a recombinant rinderpest vaccine. Vet Rec 1995; 137: 669-70.
17. Boulanger D, Brochier B, Crouch A, et al. Comparison between the susceptibilities of the red fox (Vulpes vulpes) to vaccinia-rabies recombinant and cowpox virus. Vaccine 1995; 13: 215-9.
18. Brochier B, Languet B, Blancou J, et al. Use of recombinant vaccinia-rabies virus for oral vaccination of fox cubs (Vulpes vulpes) against rabies. Vet Microbiol 1988; 18: 103-8.
19. Coupar BE, Andrew ME, Both GW, Boyle DB. Temporal regulation of influenza haemagglutin expression in vaccinia virus recombinants and effects of the immune response. European J Immunol 1986; 16: 1479-87.